Evidence map›Paper›PMID 39595645›Full record

ArticleBiomolecules2024

Advances in the Regulation of Periostin for Osteoarthritic Cartilage Repair Applications.

Sunny Y Shih, Michael P Grant, Laura M Epure, Muskan Alad, Sophie Lerouge, Olga L Huk, Stephane G Bergeron, David J Zukor, Géraldine Merle, Hee-Jeong Im and 2 more

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sunny Y ShihDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Michael P GrantDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.ORCID 0000-0003-3758-5009
Laura M EpureDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Muskan AladDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Sophie LerougeDepartment of Mechanical Engineering, École de Technologie Supérieure (ETS), Montreal, QC H3C 1K3, Canada.ORCID 0000-0002-4992-5552
Olga L HukDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Stephane G BergeronDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.ORCID 0000-0003-2713-6453
David J ZukorDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Géraldine MerleDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.ORCID 0000-0001-8044-985X
Hee-Jeong ImDepartment of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA.ORCID 0000-0001-7672-269X
John AntoniouDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Fackson MwaleDepartment of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.

Funding

Validation of Novel Target for OA TreatmentR01AR077890 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROYSTON, THOMAS J · 2020 to 2020
$4.2M
BLRD VA I01 BX002647BLRD VA IK6 BX004477Canadian Institutes of Health Research (CIHR) PJT 180252.NIAMS NIH HHS R01 AR077890
6 · The paper itself

Abstract

Emerging evidence indicates periostin (POSTN) is upregulated in patients with OA, and studies have shown that it can induce the activation of inflammatory cytokines and catabolic enzymes, making it a potential therapeutic target. Link N (LN) is a peptide fragment derived from the link protein and has been demonstrated as an anabolic-like factor and anti-catabolic and anti-inflammatory factors both in vitro and in vivo. This study aims to determine if LN can regulate POSTN expression and function in OA cartilage. Articular cartilage was recovered from donors undergoing total knee replacements to isolate chondrocytes and prepare osteochondral explants. Cells and explants were treated with POSTN and LN (1 and 100 μg) and measured for changes in POSTN expression and various matrix proteins, catabolic and proinflammatory factors, and signaling. To determine the effects of POSTN expression in vivo, a rabbit OA model was used. Immunoprecipitation and in silico modeling were used to determine peptide/POSTN interactions. Western blotting, PCR, and immunohistochemistry demonstrated that LN decreased POSTN expression both in vitro and in vivo. LN was also able to directly inhibit POSTN signaling in OA chondrocytes. In silico docking suggested the direct interaction of LN with POSTN at residues responsible for its oligomerization. Immunoprecipitation experiments confirmed the direct interaction of LN with POSTN and the destabilization of its oligomerization. This study demonstrates the ability of a peptide, LN, to suppress the overexpression and function of POSTN in OA cartilage.

Indexed as

Cartilage, ArticularCell Adhesion MoleculesChondrocytesOsteoarthritisAgedAnimalsCells, CulturedFemaleHumansMaleMiddle AgedMolecular Docking SimulationPeptide FragmentsPeriostinRabbitsSignal TransductionCell Adhesion MoleculesPeptide FragmentsPeriostinPOSTN protein, humancartilagechondrocyteLink Nosteoarthritisperiostin

Identifiers

PMID39595645
PMCPMC11592007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.